Frequency

Percent

Valid Percent

Cumulative Percent

CD10

Positive

17

63.0

63.0

63.0

Negative

10

37.0

37.0

100.0

Total

27

100.0

100.0

BCL2

Positive

22

81.5

81.5

81.5

Negative

5

18.5

18.5

100.0

Total

27

100.0

100.0

BCL6

Positive

17

63.0

63.0

63.0

Negative

10

37.0

37.0

100.0

Total

27

100.0

100.0

MUM1

Positive

12

44.4

44.4

44.4

Negative

15

55.6

55.6

100.0

Total

27

100.0

100.0

Ki67

≤20%

14

51.9

51.9

51.9

21%=40%

6

22.2

22.2

74.1

41%=60%

4

14.8

14.8

88.9

>60%

3

11.1

11.1

100.0

Total

27

100.0

100.0

FLIPI

Low

1

3.7

3.7

3.7

Intermediate

8

29.6

29.6

33.3

High

18

66.7

66.7

100.0

Total

27

100.0

100.0

Ann Arbor Stage

IIB

1

3.7

3.7

3.7

IIIA

1

3.7

3.7

7.4

IIIB

18

66.7

66.7

74.1

IVB

7

25.9

25.9

100.0

Total

27

100.0

100.0

Bone Marrow Involvement

No

22

81.5

81.5

81.5

Yes

5

18.5

18.5

100.0

Total

27

100.0

100.0

Hepatosplenomegaly

No

20

74.1

74.1

74.1

Yes

7

25.9

25.9

100.0

Total

27

100.0

100.0

B Syndrome

Yes

26

96.3

96.3

96.3

No

1

3.7

3.7

100.0

Total

27

100.0

100.0

High Tumor Burden

Yes

27

100.0

100.0

100.0